Dana-Farber Cancer Institute [Boston] ( Site 1201)

Boston, Massachusetts 02215

0 studies enrolling now · 1 studies all time

What they study most

Small Cell Lung Cancer (SCLC)

Studies at this site

• A Study of Pembrolizumab (MK-3475) in Combination With Etoposide/Platinum (Cisplatin or Carboplatin) for Participants With Extensive Stage Small Cell Lung Cancer (MK-3475-604/KEYNOTE-604) — Completed